Allergan’s Botox trial underway in Vermont
The trial against American multinational pharmaceutical company Allergan, Inc., began during the first week of November at a local court in Burlington, Vermont, and will continue until Friday, November 21, the Burlington Free Press reported.
The case stemmed from a lawsuit filed by a New York couple who claimed that their six-year-old son, who suffers from cerebral palsy, experienced a life-threatening reaction after taking Botox to reduce leg spasms. In their legal complaint, Kevin and Lori Drake argued that Allergan did not properly warn the public of the potential negative side effects of their products, thereby perpetuating negligence and violating the Vermont Consumer Fraud Act.
Botox, which is also known as botolinum toxin and is manufactured by Allergan, paralyzes a muscle when it is injected in that specific part of the body, decreasing muscle activity and therefore preventing wrinkle development. It is used often in cosmetic applications.
The couple said the boy was not suffering from seizures before he underwent the treatment, and now he must be constantly monitored.
If you have been injured by a defective product or failed to receive warning of possible pharmaceutical dangers, you have the legal right to pursue financial compensation from these manufacturers. Call our New York attorneys at Hach & Rose, LLP, today by dialing (212) 779-0057 to enlist our legal services.